The market for antineoplastic agents is expected to reach a value of US$ 126.71 billion in 2023 and grow at an estimated CAGR of 8.5% between 2023 and 2033. Cancer is treated with pharmaceuticals known as antineoplastic agents or drugs. Antineoplastic drugs sometimes go by the labels chemotherapy, cytotoxic, and anticancer. These drugs are available as liquids or pills. People are more aware of cancer and its therapies as it becomes a more widespread problem worldwide.
The expansion of the global healthcare infrastructure is predicted to support market growth over the course of the forecast period. The development of anti-neoplastic medicines is being hampered by a number of problems, including prohibitive drug costs and onerous product approval rules.
Download a Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8071?PJ
Biological agents are gaining traction since the outbreak of COVID-19 and high developments are seen in the biological treatment of cancer disorders. To deliver advanced treatment to target patients, various medical researchers are concentrating on nanotechnology. The immune system of the patient is used in biological therapy to treat cancer while protecting healthy cells.
North America and Europe are dominating regional markets for antineoplastic agent producers due to the rising cases of cancers and growing medical tourism. While the Asia Pacific antineoplastic agents market is expected to increase at the fastest pace during the forecast period due to the rapidly developing healthcare industry, key market players are planting their manufacturing units in the region to earn more income.
Key Takeaways from Market Study
- The global market for antineoplastic agents is projected to reach US$ 286.49 billion by 2033.
- Germany’s market is predicted to expand at a CAGR of 6% during the forecast period.
- Demand for antineoplastic agents in China is expected to rise at an impressive CAGR of 12% during the forecast period.
- The demand for biological agents is predicted to rise at a high CAGR of 9% from 2023 to 2033.
Winning Strategy
Key manufacturers of antineoplastic agents are fully focused on developing advanced drugs, for which they are highly investing in R&D activities. This will not only help them to gain more revenue but also to reach dominating market position. Other strategies such as acquisitions, mergers and collaborations are adopted by manufacturers of antineoplastic agents.
- The acquisition of Tidal Therapeutics, a pre-clinical biotech firm in charge of creating an mRNA-based research platform, by Sanofi was announced in April 2021. With the aid of this acquisition, Sanofi will be able to increase the scope of its research in the fields of oncology, immunology, and other diseases.
Key companies in Antineoplastic Agents Market
- AbbVie
- Abraxis
- AstraZeneca
- Baekdu Mountain Pharmaceutical
- Baida Pharmaceutical
- Bayer
- Biogen Idec
- BMS
- Celgene
- CTTQ
- Eisai
Key Segments of Antineoplastic Agents Industry Research
- By Product :
- Chemotherapeutic Agents
- Biological/Immunotherapeutic Agents
- Personalized Medicines
- Alkylating and Alkylating-like Agents
- Hormonal Agents, Miscellaneous Agents
- By End User :
- Hospitals
- Clinics
- Cancer Rehabilitation Centers
- Ambulatory Surgical Centers
- By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
More Valuable Insights on Offer
Fact.MR, in its new offering, presents an unbiased analysis of the global antineoplastic agents market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.
The study divulges essential insights on the market on the basis of product (chemotherapeutic agents, biological/immunotherapeutic agents, personalized medicines, alkylating & alkylating-like agents, hormonal agents, miscellaneous agents) and end user (hospitals, clinics, cancer rehabilitation centers, ambulatory surgical centers), across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and MEA).
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8071?PJ
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions/Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product modifications /Innovation/p>
4. Key Success Factors
4.1. Strategic Developments
4.2. Key regulations
4.3. Product USPs /Technology
4.4. List of Manufacturers and Providers
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP outlook
5.1.2. Increasing R&D Expenditure
TOC Contd…..
contact:
US Office:
11140 Rockville Pike
Suite 400
Rockville, Maryland 20852
United States of America
Phone: +1 (628) 251-1583
Email: [email protected]
